Revolutionary Malaria Vaccine for Infants: A Leap Towards Eradicating Childhood Deaths

New Study Reveals R21/Matrix-M Vaccine's High Efficacy in Protecting Young Children Against Malaria

Feb 16, 2024

∙ Paid

A medical researcher in a laboratory, wearing a white lab coat and safety glasses, is examining a microscope slide. Behind the researcher, a world map highlights Africa with a symbolic protective shield, symbolizing the protection against malaria. The scene conveys hope, innovation, and global health without using any text, numbers, or representations of children.

Topline:

A groundbreaking phase 3 study unveils that the new R21/Matrix-M malaria vaccine offers protection rates of 68%-75% in children under 1.5 years, marking a significant stride in malaria prevention and promising to fill the global demand for effective vaccines.

Study Details:

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.